Sepsis-3: renewed determinations, potential problems and further practical foot steps


Sepsis-3: renewed determinations, potential problems and further practical foot steps

Author Biographies

І. А. Кryvoruchko, Kharkiv National Medical University МH of Ukraine

Igor A. Kryvoruchko, MD, PhD, full professor,
Chief of the Department of Surgery No 2
Kharkiv National Medical University, Ukraine.
4 Nauky Ave., 61022, Kharkiv, Ukraine,

V. V. Boyko, Zaytsev Іnstitute of General and Urgent Surgery, Kharkiv

Boyko Valeriy V., MD, PhD, full professor,
director of Zaytsev Institute of General and Urgent Surgery
head of department of surgery No 1
Kharkiv National Medical University
Adress: 1 Balakireva entry, 61103, Kharkiv, Ukraine,
tel.: +38(057)3494125

Yu. V. Іvanova, Kharkiv National Medical University МH of Ukraine

Yulia Ivanova – MD, PhD,
Principal Research Scientist
Department of surgical infections
Zaycev Institute of General and Urgent Surgery
61018, Ukraine, Kharkov, v’ezd Balakireva, 1.
Tel.: 057-349-41-94.

S. А. Аndreieshchev, Shupyk National Medical Academy of Postgraduate Education, Kyiv

Andreieshchev Sergii A., MD, PhD, associate professor,
associate professor Department of Surgery and Transplantology,
Shupyk National Medical Academy of Postgraduate Education.
30 Heroiv Sevastopolia Str., 03680, Kyiv, Ukraina,
+38 (044) 4081811


Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):3806. doi: 10.1016/S2213-2600(14)70061-X.

Rhee C, Dantes R, Epstein L, et al. CDC Prevention Epicenter Program. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017;318(13):1241-9. doi:10.1001/jama.2017.13836.

Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90-2. doi:10.1001/jama.2014.5804.

Sepsis Alliance. Sepsis fact sheet. [cited 2018 Dec 05]. Available from:

Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA. 1997;277(13):1058-63. PMID: 9091694.

Heffner AC, Horton JM, Marchick MR, Jones A. E. Etiology of Illness in Patients with Severe Sepsis Admitted to the Hospital from the Emergency Department. Clin Infect Dis. 2010;50(6):814-20. doi: 10.1086/650580.

Nathan C. Points of control in inflammation. Nature. 2002;420(6917):846-52. doi: 10.1038/nature01320.

Reinhart К, Bauer M, Riedemann Niels C, Christiane S. Hartoga Christiane S. New Approaches to Sepsis: Molecular Diagnostics and Biomarkers. Clin. Microbiol. Rev. 2012;25(4):609-34. doi: 10.1128/CMR.00016-12.

Bone RC. Тoward an Epidemiology and Natural History of SIRS. JAMA. 1992; 268(24):3452-5. PMID: 1460735.

Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 1996;24(7):1125-8. PMID: 8674323.

Bone RС. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med. 1996;24(1):163-72. PMID: 8565523.

Marshall JR, Aarts MA. From Celsus to Galen to Bone: the illnesses, syndromes and diseases of acute inflammation. Year of Intensive Care and Emergency Medicine.

Springer. 2001;4:312.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20(6):864-874. PMID: 1597042.

Vincent JL. Dear SIRS, I’m sorry to say that I’don’t like you. Crit. Care Med. 1997; 25:372374. PMID: 9034279.

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29(4): 530538. doi: 10.1097/01.CCM.0000050454.01978.3B.

Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A,et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis3). JAMA. 2016;315(8): 76274. doi: 10.1001/jama.2016.0288

ShankarHari M, Phillips G, Levy M, , Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis3). JAMA. 2016;315(8):77587. doi: 10.1001/jama.2016.0289.

Singer M, Deuschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus definitions for Sepsis and Septic Shock (Sepsis3). JAMA. 2016;315(8): 801810. doi:10.1001/jama.2016.0287.

Angus DC, van der Poll T. Severe sepsis and septic shock. N. Engl. J. Med. 2013;369(9): 84051. doi: 10.1056/NEJMra1208623.

Deutschman CS, Tracey KJ. Sepsis: current dogma and new Perspectives. Immunity. 2014;40(4):46375. doi: 10.1016/j.immuni.2014.04.001.

Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 2013;13(12):862-74. doi: 10.1038/nri3552.

Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence. 2014; 5 (1): 3644. doi: 10.4161/viru.25436.

Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 1996; 24(7):1125-8 . PMID: 8674323.

Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH. Predictors of 30day mortality and hospital costs in patients with ventilatorassociated pneumonia attributed to potentially antibiotic-resistant gramnegative bacteria. Chest. 2008; 134:281-7. doi: 10.1378/chest.08-1116.

Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413-422. doi: 10.1001/jama.300.4.413.

Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care. 2011;15(4):183 doi:10.1186/cc10332.

Volk HD, Reinke P, Docke WD. Clinical aspects: from systemic inflammation to ‘immunoparalysis’. Chem. Immunol. 2000; 74:162-77. PMID: 10608087.

Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood. 2000; 96:218-23. PMID: 10891454.

Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 2009;15:496-497. doi: 10.1038/nm0509-496.

Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594-605. doi: 10.1001/jama.2011.1829

Hotchkiss RS, Opal S. Immunotherapy for sepsis - a new approach against an ancient foe. N. Engl. J. Med. 2010;363(1):87-89. doi: 10.1056/NEJMcibr1004371.

Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Crit. Care Med. 1996;125(8):680-7. doi: 10.7326/0003-4819-125-8-199610150-00009.

Matzinger P. The danger model: a renewed sense of self. Science. 2002; 296(5566):301-5. doi: 10.1126/science.1071059.

Zhang Q, Raoof M, Chen Yu, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010; 464(7285):104-7. doi: 10.1038/nature08780.

Grazioli S, Pugin J. Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases. Front Immunol. 2018;9:832. doi: 10.3389/fimmu.2018.00832.

Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR, Osborn TM, et al. Lactate measurements in sepsis - induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit. Care Med. 2015;43(3):56773. doi: 10.1097/CCM.0000000000000742.

Sartelli M, Catena F, Abu-Zidan FM, Ansaloni L, Biffl WL, Boermeester MA, et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg. 2017;12:22. doi: 10.1186/s13017-017-0132-7.

Sartelli M, Kluger Y, Ansaloni L, Hardcastle TC, Rello J, Watkins RR, et al. Raising concerns about the Sepsis-3 definitions. World J Emerg Surg. 2018;13:6. doi: 10.1186/s13017-018-0165-6.

Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens YE, Avondo A, et al. Prognostic accuracy of Sepsis-3 criteria for in  hospital mortality among patients with suspected infection presenting to the emergency department. JAMA. 2017;317(3):301-8. doi: 10.1001/jama.2016.20329.

Angus D.C., van der Poll T. Severe sepsis and septic shock. N. Engl. J. Med. 2013;369(9):840-51. doi: 10.1056/NEJMra1208623.

Carneiro AH, Póvoa P, Gomes JA. Dear Sepsis3, we are sorry to say that we don’t like you. Revista Brasileira de Terapia Intensiva. 2017;29(1):4-8. doi: 10.5935/0103-507X.20170002.

De Waele JJ. Early source control in sepsis. Langenbeck’s Arch. Surg. 2010;395:489-94. doi: 10.1007/s00423-010-0650-1.

Sotto A, Lefrant JY, FabbroPeray P, Muller L, Tafuri J, Navarro F, et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother. 2002; 50:569-576. doi: 10.1093/jac/dkf167.

Sartelli M, Catena F, Ansaloni L, Coccolini F, Corbella D, Moore EE, et al. Complicated intraabdominal infections worldwide: the definitive data of the CIAOW study. World J Emerg Surg. 2014;9:37. doi: org/10.1186/17497922937.

Raith E.P., Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R,et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in  hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA.2017;(3):317:290-300. doi: 10.1001/jama.2016.20328.

Tusgul S, Carron PN, Yersin B, Calandra T, Dami F. Low sensitivity of qSOFA, SIRS criteria and sepsis definition to identify infected patients at risk of complication in the prehospital setting and at the emergency department triage. Scand. J. Trauma. Resusc. Emerg. Med. 2017;25(1):108. doi: 10.1186/s130490170449y.

Askim A, Moser F, Gustad LT, Stene H, Gundersen M, Asvold BO, et al. Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality—a prospective study of patients admitted with infection to the emergency department. Scand. J. Trauma. Resusc. Emerg. Med. 2017;25(1):56. doi: 10.1186/s13049-017-0399-4.

Williams JM, Greenslade JH, McKenzie JV, Chu K, Brown AFT, Lipman J. Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection. Chest. 2017; 151(3):586-596. doi: 10.1016/j.chest.2016.10.057.

GiamarellosBourboulis E.J., Tsaganos T., Tsangaris I., Lada M, Routsi C, Sinapidis D, et al. Validation of the new Sepsis-3 definitions: proposal for improvement in early risk identification. Clin Microbiol Infect. 2017; 23(2):104-9. doi: 10.1016/j.cmi.2016.11.003.

Simpson SQ. SIRS in the Time of Sepsis3. Chest. 2018;153(1): 348. doi: 10.1016/j.chest.2017.10.006.

Cobb JP, Moore EE, Hayden DL, Minei JP, Cuschieri J, Yang J, et al. Validation of the riboleukogram to detect ventilatorassociated pneumonia after severe injury. Ann. Surg. 2009;250(4):531-9. doi: 10.1097/SLA.0b013e3181b8fbd5.

Sutherland A, Thomas M, Brandon RA, Brandon RB, Lipman J, Tang B, et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit. Care. 2011;15(3):R149. doi:10.1186/cc10274.

Larsen FF, Petersen JA. Novel biomarkers for sepsis: A narrative review. Eur. J. Intern. Med. 2017;45:4650. doi: 10.1016/j.ejim.2017.09.030.

Povoa P, Souza-Dantas VC, Soares M, Salluh JF. C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit. Care. 2011;15(3):R129. doi:10.1186/cc10242.

Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit. Care. 2006;10(5):R145. doi:10.1186/cc5067.

Tobias PS, Mathison J, Mintz D, Lee JD, Kravchenko V, Kato K, et al. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am. J. Respir. Cell Mol. Biol. 1992;7(3):239-45. doi: 10.1165/ajrcmb/7.3.239/.

Bottazzi B, Garlanda C, Cotena A, Moalli F, Jaillon S, Deban L, et al. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol. Rev. 2009; 227(1):9-18. doi: 10.1111/j.1600-065X.2008.00719.x.

Mauri T., Bellani G., Patroniti N. Coppadoro A, Peri G, Cuccovillo I, et al. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med. 2010; 36(4):621-9. doi: 10.1007/s00134-010-1752-5.

Huttunen R, Hurme M, Aittoniemi J Huhtala H, Vuento R, Laine J, et al. High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study. PLoS One. 2011;6(3):e17653. doi:10.1371/journal.pone.0017653.

Vänskä M, Koivula I, Hämäläinen S, Pulkki K, Nousiainen T, Jantunen E, et al. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients. Haematologica. 2011; 96(9):1385-9. doi: 10.3324/haematol.2011.044925.

Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit. Care. 2010;14(1):R15. doi:10.1186/cc8872.

Tamayo E, Fernández A, Almansa R, Carrasco E, Heredia M, Lajo C, et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur. Cytokine Netw. 2011; 22(2):82-7. doi: 10.1684/ecn.2011.0281.

Sherwin C, Broadbent R, Young S, Worth J, McCaffrey F, Medlicott NJ, et al. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am. J. Perinatol. 2008; 25(10):629-36. doi: 10.1055/s-0028-1090585.

Sakr Y, Reinhart K, Hagel S, Kientopf M, Brunkhorst F. Antithrombin levels, morbidity, and mortality in a surgical intensive care unit. Anesth. Analg. 2007;105(3):715-23. doi: 10.1213/

Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, et al. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit. Care Med. 2000;28(7):2209-16. PMID: 10921542.

Zakariah AN, Cozzi SM, Van Nuffelen M, Clausi CM, Pradier O, Vincent JL. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit. Care Med. 2008;36(5):1507-12. doi: 10.1097/CCM.0b013e3181709f19.

Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000;164(10):4991-5. doi: 10.4049/jimmunol.164.10.4991.

Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 1990; 9(2):467-74. PMID: 689240.

Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J. Clin. Endocrinol. Metab. 1996;81(4):1449-53. doi: 10.1210/jcem.81.4.8636349.

Qureshi SS, Lewis SM, Gant VA, Treacher D, Davis BH, Brown KA. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin. Exp. Immunol. 2001;125(2):258-65. doi: 10.1046/j.1365-2249.2001.01596.x.

Gibot S, Béné MC, Noel R, Massin F, Guy J, Cravoisy A, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am. J. Respir. Crit. Care Med. 2012;186(1):65-71. doi: 10.1164/rccm.201201-0037OC.

Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764-9. doi: 10.1007/s10156-011-0254-x.

Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. 2011;412 (23-24):2157-61. doi: 10.1016/j.cca.2011.07.024.

Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med. 2011;49(5):937-9. doi: 10.1515/CCLM.2011.145.

Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueckmann M, et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care. 2014; 18(5): 507. doi: 10.1186/s13054-014-0507-z

Hassan EA, Abdel Rehim A.S., Ahmed A.O., Abdullahtif H., Attia A. Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients. Medicina (Kaunas). 2019;55(2):36. doi: 10.3390/medicina55020036.

Yang HS, Hur M, Yi A, Kim H2, Lee S, Kim SN. Prognostic value of presepsin in adult patients with sepsis: Systematic review and meta-analysis. PLoS One. 2018;13(1): e0191486. doi: 10.1371/journal.pone.0191486.

Seymour CW, Kennedy JN., Wang S, Chang CH, Elliott CF, Xu Z, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019. doi:10.1001/jama.2019.5791.

How to Cite
КryvoruchkoІ. А., Boyko, V. V., ІvanovaY. V., & АndreieshchevS. А. (2019). Sepsis-3: renewed determinations, potential problems and further practical foot steps . Klinicheskaia Khirurgiia, 86(6), 60-72.

Most read articles by the same author(s)